Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
663.86 -1.60 (-0.24%) 02/12/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 671.78 +7.92 (+1.19%) 17:41 ET
Earnings Estimates for Wed, Feb 12th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Earnings History - Surprises*

Qtr Ending 03/24 Qtr Ending 06/24 Qtr Ending 09/24 Qtr Ending 12/24
Reported $7.97 $10.10 $11.73 $9.90
Estimate $8.46 $8.93 $10.06 $9.62
Difference -0.49 +1.17 +1.67 +0.28
Surprise -5.79% +13.10% +16.60% +2.91%

Last 4 Quarters

  • Key:
  • Reported
  • Estimate

Earnings Estimates

Next Earnings Release Date - N/A Current Qtr 03/2025 Next Qtr 06/2025 Fiscal Yr 12/2025 Fiscal Yr 12/2026
Average Earnings Estimate 7.86 9.17 35.92 38.02
Number of Estimates 7 6 10 8
High Estimate 10.40 10.54 43.65 47.22
Low Estimate 6.22 7.38 27.82 27.99
Prior Year 7.97 10.10 38.62 35.92
Growth Rate Est. (year over year) Growth Rate Est. (yoy) -1.38% -9.21% -6.99% +5.85%

*Earnings numbers reflect diluted earnings per share, reported before non-recurring items.

Key Statistics

Market Cap, $K 73,127,392
Shares Outstanding, K 109,890
Price/Earnings Forward 19.22
Price/Earnings ttm 17.39
P/E to Growth 2.32
Earnings Per Share ttm 39.70
Most Recent Earnings $12.07 on 02/04/25
60-Month Beta 0.08
Annual Sales, $M 14,202
Annual Net Income, $M 4,413
Annual Dividend Yield 0.00 (0.00%)
Most Recent Dividend N/A on N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion